Inventor

BORZILLERI ROBERT M

US57 patents

⚠️ This page may combine multiple inventors who share the name “BORZILLERI ROBERT M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

41 patents

US6605599B1Aug 12, 2003

Epothilone derivatives

BRISTOL MYERS SQUIBB CO90 citations98

US6365749B1Apr 2, 2002

Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs

BRISTOL MYERS SQUIBB CO85 citations98

US6291684B1Sep 18, 2001

Process for the preparation of aziridinyl epothilones from oxiranyl epothilones

BRISTOL MYERS SQUIBB CO76 citations96

US7851489B2Dec 14, 2010

Pyridinone compounds

BRISTOL MYERS SQUIBB CO32 citations92

US7459562B2Dec 2, 2008

Monocyclic heterocycles as kinase inhibitors

BRISTOL MYERS SQUIBB CO27 citations92

US7439246B2Oct 21, 2008

Fused heterocyclic kinase inhibitors

BRISTOL MYERS SQUIBB CO30 citations92

US7348325B2Mar 25, 2008

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO23 citations92

US6951859B2Oct 4, 2005

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO38 citations92

US6498257B1Dec 24, 2002

2,3-olefinic epothilone derivatives

BRISTOL MYERS SQUIBB CO38 citations92

US7173031B2Feb 6, 2007

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO25 citations91

US9527871B2Dec 27, 2016

Benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO5 citations84

US9526801B2Dec 27, 2016

Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO13 citations84

US7566784B2Jul 28, 2009

Bicyclic heterocycles as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations84

US6831090B2Dec 14, 2004

2,3-olefinic epothilone derivatives

BRISTOL MYERS SQUIBB CO14 citations84

US8754230B2Jun 17, 2014

4-pyridinone compounds and their use for cancer

BRISTOL MYERS SQUIBB CO14 citations83

US7714138B2May 11, 2010

Monocyclic heterocycles as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations83

US7470693B2Dec 30, 2008

Oxalamide derivatives as kinase inhibitors

BRISTOL MYERS SQUIBB CO17 citations83

US8889712B2Nov 18, 2014

IAP antagonists

BRISTOL MYERS SQUIBB CO13 citations82

US7125899B2Oct 24, 2006

Epothilone derivatives

BRISTOL MYERS SQUIBB CO8 citations82

US7241755B2Jul 10, 2007

Epothilone derivatives

BRISTOL MYERS SQUIBB CO4 citations74

US9676794B2Jun 13, 2017

Benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO3 citations73

US7084160B2Aug 1, 2006

Heterocyclic inhibitors of kinases

BRISTOL MYERS SQUIBB CO6 citations73

US9708316B2Jul 18, 2017

TGFβR antagonists

BRISTOL MYERS SQUIBB CO5 citations72

US9688694B2Jun 27, 2017

Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses

BRISTOL MYERS SQUIBB CO3 citations70

US8921542B2Dec 30, 2014

Epothilone derivatives

BRISTOL MYERS SQUIBB CO1 citations63

USRE41911ENov 2, 2010

Epothilone derivatives

BRISTOL MYERS SQUIBB CO1 citations63

USRE41893EOct 26, 2010

Epothilone derivatives

BRISTOL MYERS SQUIBB CO2 citations63

US7989477B2Aug 2, 2011

Monocyclic heterocycles as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations62

US7880004B2Feb 1, 2011

Met kinase inhibitors

BRISTOL MYERS SQUIBB CO4 citations62

US7547782B2Jun 16, 2009

Met kinase inhibitors

BRISTOL MYERS SQUIBB CO6 citations62

USRE39356EOct 17, 2006

Process for the preparation of epothilone analogs

BRISTOL MYERS SQUIBB CO3 citations61

US10336761B2Jul 2, 2019

TGFβ receptor antagonist

BRISTOL MYERS SQUIBB CO1 citations60

US10292985B2May 21, 2019

TGF beta receptor antagonists

BRISTOL MYERS SQUIBB CO1 citations58

US10112975B2Oct 30, 2018

Benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO0 citations52

US9822144B2Nov 21, 2017

Benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO0 citations52

US9822112B2Nov 21, 2017

Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO0 citations52

US9676775B2Jun 13, 2017

Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using

BRISTOL MYERS SQUIBB CO0 citations52

USRE41895EOct 26, 2010

Epothilone derivatives

BRISTOL MYERS SQUIBB CO0 citations52

US7547711B2Jun 16, 2009

Heterocyclic inhibitors of kinases

BRISTOL MYERS SQUIBB CO0 citations51

US10961239B2Mar 30, 2021

TGF beta receptor antagonists

BRISTOL MYERS SQUIBB CO0 citations49

US9902740B2Feb 27, 2018

Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses

BRISTOL MYERS SQUIBB CO0 citations49

BORZILLERI ROBERT M

3 patents

US8536200B2Sep 17, 2013

Pyridinone compounds

BORZILLERI ROBERT M13 citations82

US8258118B2Sep 4, 2012

4-pyridinone compounds and their use for cancer

BORZILLERI ROBERT M4 citations62

US8124768B2Feb 28, 2012

4-pyridinone compounds and their use for cancer

BORZILLERI ROBERT M3 citations62

RIGEL PHARMACEUTICALS INC

3 patents

US9884868B2Feb 6, 2018

TGF-beta inhibitors

RIGEL PHARMACEUTICALS INC2 citations71

US11352360B2Jun 7, 2022

TGF-beta inhibitors

RIGEL PHARMACEUTICALS INC0 citations60

US10287295B2May 14, 2019

TGF-β inhibitors

RIGEL PHARMACEUTICALS INC0 citations51

BRISTOL MYERS SQUIBB COMPNAY

1 patent

US6800653B2Oct 5, 2004

Epothilone derivatives

BRISTOL MYERS SQUIBB COMPNAY59 citations94

VITE GREGORY D

1 patent

US8536327B2Sep 17, 2013

Epothilone derivatives

VITE GREGORY D1 citations61

KIM KYOUNG S

1 patent

US8501992B2Aug 6, 2013

Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors

KIM KYOUNG S3 citations57

Showing the top 50 of 57 patents by PatentIndex Score.